Canine Lymphadenopathy Study Guide

Overview and Clinical Importance

Lymphadenopathy refers to the enlargement or pathological change of lymph nodes and is one of the most common clinical findings in canine practice. While the term lymphadenomegaly is technically more accurate for describing lymph node enlargement, lymphadenopathy is used synonymously in clinical practice. This finding can indicate a wide spectrum of underlying conditions, ranging from benign reactive processes to life-threatening malignancies such as lymphoma. The ability to accurately assess, diagnose, and manage lymphadenopathy is essential for NAVLE success and clinical practice.

Lymphadenopathy may involve peripheral (palpable) lymph nodes, internal visceral lymph nodes, or both. It can be localized (affecting a single node or regional group), regional (affecting nodes in a specific anatomic area), or generalized (affecting multiple lymph node regions throughout the body). Understanding the pattern of lymph node involvement is critical for developing an appropriate differential diagnosis list.

Anatomy of Canine Peripheral Lymph Nodes

The lymphatic system is essential for immune surveillance and fluid homeostasis. Lymph nodes filter lymphatic fluid and serve as sites for antigen presentation and immune cell activation. Understanding peripheral lymph node anatomy is critical for systematic physical examination and accurate sample collection.

Palpable Peripheral Lymph Nodes

Internal Lymph Nodes

Internal lymph nodes (retropharyngeal, tracheobronchial, sternal, mesenteric, medial iliac) cannot be palpated unless markedly enlarged. Imaging modalities such as radiography, ultrasonography, or CT are required to evaluate these nodes. The medial retropharyngeal lymph node serves as the collecting center for head drainage and receives lymph from the mandibular, parotid, and lateral retropharyngeal nodes.

Differential Diagnosis of Lymphadenopathy

The differential diagnosis for canine lymphadenopathy is extensive and includes neoplastic, infectious, inflammatory, and reactive conditions. The distribution pattern (localized versus generalized) provides important diagnostic clues.

Causes by Distribution Pattern

Diagnostic Approach to Lymphadenopathy

Physical Examination

Systematic palpation of all peripheral lymph nodes should be performed during every physical examination. Assess each node for size, shape, consistency, mobility, symmetry, and pain. Normal lymph nodes are small, soft, mobile, and non-painful. Enlarged nodes may feel firm or rubbery (lymphoma), fluctuant (abscess), fixed (metastatic invasion), or painful (acute inflammation).

Fine Needle Aspiration and Cytology

Fine needle aspiration (FNA) is the most important initial diagnostic test for lymphadenopathy. It is minimally invasive, inexpensive, rapid, and highly diagnostic in most cases. Use a 22-25 gauge needle with either aspiration or non-aspiration (tattooing) technique. Prepare thin smears with gentle pressure to avoid cell rupture.

Cytologic Interpretation

Additional Diagnostics

Major Causes of Canine Lymphadenopathy

Multicentric Lymphoma

Multicentric lymphoma is the most common form of canine lymphoma, accounting for approximately 80% of cases, and is the single most common cause of generalized lymphadenopathy in dogs. It represents a neoplastic proliferation of lymphocytes affecting multiple lymph node regions simultaneously.

Clinical Presentation

• Signalment: Middle-aged to older dogs (median 6-9 years); predisposed breeds include Golden Retrievers, Boxers, Bulldogs, German Shepherds, Rottweilers
• Clinical signs: Painless, bilateral, symmetrical peripheral lymphadenomegaly; may be incidental finding; 60-80% are substage a (asymptomatic)
• Substage b signs: Lethargy, anorexia, weight loss, vomiting, diarrhea, polyuria/polydipsia (if hypercalcemic)
• Physical exam: Generalized lymphadenomegaly (nodes may be 5-10x normal size), hepatosplenomegaly

WHO Clinical Staging System

Prognostic Factors

• Immunophenotype: B-cell lymphoma has better prognosis than T-cell lymphoma (median survival 12-14 months vs 6-8 months with treatment)
• Substage: Substage a (asymptomatic) has better prognosis than substage b
• Hypercalcemia: Negative prognostic factor; associated with T-cell phenotype
• Prior corticosteroid treatment: Reduces response to subsequent chemotherapy
• Mediastinal mass: Negative predictor; associated with T-cell phenotype

Treatment Options

Ehrlichiosis

Canine ehrlichiosis is a tick-borne rickettsial disease caused primarily by Ehrlichia canis (transmitted by the brown dog tick, Rhipicephalus sanguineus) and Ehrlichia ewingii (transmitted by the Lone Star tick). German Shepherds are predisposed to severe, chronic ehrlichiosis.

Clinical Phases

Diagnosis and Treatment

• Diagnosis: SNAP 4Dx Plus (antibody detection), serology (IFA titers), PCR; thrombocytopenia is most consistent hematologic finding; hyperglobulinemia common
• Treatment: Doxycycline 5-10 mg/kg PO q12h for 28-30 days; supportive care; blood transfusion if severely anemic/thrombocytopenic
• Prognosis: Excellent if treated in acute phase; guarded to poor for chronic phase with bone marrow involvement

Systemic Fungal Infections

Systemic mycoses are important causes of generalized lymphadenopathy, particularly in endemic regions. The most common fungal causes are Blastomyces dermatitidis and Histoplasma capsulatum. Geographic history is essential for diagnosis.

Metastatic Neoplasia to Lymph Nodes

Regional lymph node assessment is critical for staging many canine tumors. Tumors with high metastatic potential to lymph nodes include mast cell tumors, melanoma, carcinomas, and histiocytic sarcoma. Note that a normal-sized lymph node does NOT rule out metastasis.

Key Points by Tumor Type

• Mast Cell Tumors: Regional lymph node evaluation essential regardless of node size; metastatic mast cells may be present without node enlargement; look for mast cell clusters and elevated mast cell numbers
• Oral Melanoma: High metastatic rate (greater than 80%); evaluate mandibular and retropharyngeal nodes; amelanotic melanoma is common
• Carcinomas: Epithelial cell clusters with criteria of malignancy; mammary carcinoma metastasizes to axillary and inguinal nodes
• Soft Tissue Sarcomas: Lower metastatic rate to lymph nodes (typically spread hematogenously to lungs); cytology less reliable due to poor exfoliation

Memory Aids and Clinical Pearls